Shinnihonseiyaku reported ordinary income of ¥5,202 million for the fiscal year ended September 2026, up 6.4% year on year, exceeding the IFIS consensus of ¥5,030 million by 3.4%. It also forecast ordinary income of ¥5,430 million for the fiscal year ending September 2027, a 4.4% increase, which is expected to be 3% above the IFIS consensus. Ordinary income for the interim period is forecast at ¥2,680 million.
Shinnihonseiyaku reported ordinary income of ¥5,202 million for the fiscal year ended September 2026, an increase of 6.4% year on year. The IFIS consensus was ¥5,030 million, and actual results were 3.4% above that level.
In its earnings forecast for the fiscal year ending September 2027, announced the same day, the company expects ordinary income of ¥5,430 million, an increase of 4.4%, which is projected to be 3% above the IFIS consensus. Ordinary income for the interim period is forecast at ¥2,680 million.
The article also lists Achilles, Nippon Nozai, Riken Technos and HABA Laboratories among stocks frequently viewed alongside the company.